{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:59Z","timestamp":1792782599219,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Medical University Graduate Student Top-notch Talent Training Program","award":["BJRC202512"],"award-info":[{"award-number":["BJRC202512"]}],"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory","award":["2025XAKJ01010033"],"award-info":[{"award-number":["2025XAKJ01010033"]}]},{"name":"Chongqing Education Commission of Science and Technology Research Project","award":["KJZD-M202400401"],"award-info":[{"award-number":["KJZD-M202400401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05969-4","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:24:51Z","timestamp":1791512691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dihydroflavonoids outperform their flavonoid counterparts in lipid-lowering efficacy based on pairwise analyses"],"prefix":"10.1007","author":[{"given":"Lie","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-9969","authenticated-orcid":false,"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"5969_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13111286","author":"C Bonfiglio","year":"2024","unstructured":"Bonfiglio C, Tatoli R, Donghia R, Guido D, Giannelli G (2024) Exploratory role of flavonoids on metabolic dysfunction-associated steatotic liver disease (MASLD) in a South Italian cohort. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13111286","journal-title":"Antioxidants (Basel)"},{"key":"5969_CR2","volume":"133","author":"YQ Cai","year":"2025","unstructured":"Cai YQ, Yuan L, Wang KY (2025) Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2\/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease. J Funct Foods 133:106041","journal-title":"J Funct Foods"},{"key":"5969_CR3","doi-asserted-by":"publisher","first-page":"e70832","DOI":"10.1002\/mco2.70832","volume":"7","author":"Z Cui","year":"2026","unstructured":"Cui Z, Du X, Amevor FK, Xia Y, Yang Y, Liu L (2026) Metabolic dysfunction-associated fatty liver disease: from pathogenesis to treatment. MedComm 7:e70832","journal-title":"MedComm"},{"key":"5969_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-J\u00e4rvinen H, Fan JG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202\u2013209","journal-title":"J Hepatol"},{"key":"5969_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10704-3","author":"Y Fouad","year":"2024","unstructured":"Fouad Y, Alboraie M, Shiha G (2024) Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatol Int. https:\/\/doi.org\/10.1007\/s12072-024-10704-3","journal-title":"Hepatol Int"},{"key":"5969_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-04060-1","volume":"25","author":"L Gao","year":"2025","unstructured":"Gao L, Fang H, Liu Y, Luo W, Gong J, Ma R (2025) Association between dietary flavonoids intake and metabolic dysfunction-associated steatotic liver disease especially in non-smokers: a cross-sectional study in US adults. BMC Gastroenterol 25:479","journal-title":"BMC Gastroenterol"},{"key":"5969_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322797","volume":"20","author":"Y He","year":"2025","unstructured":"He Y, Chang Y, Liu X, Li Y, Ji W, Wang Z, Cui J (2025) Associations of flavonoid intakes with metabolic dysfunction-associated steatotic liver disease in US adults. PLoS ONE 20:e0322797","journal-title":"PLoS ONE"},{"key":"5969_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.118731","volume":"243","author":"J Huang","year":"2020","unstructured":"Huang J, He Z, Cheng R, Cheng Z, Wang S, Wu X, Niu B, Shen GX, Liao X (2020) Assessment of binding interaction dihydromyricetin and myricetin with bovine lactoferrin and effects on antioxidant activity. Spectrochim Acta A Mol Biomol Spectrosc 243:118731","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"5969_CR9","doi-asserted-by":"publisher","first-page":"1660065","DOI":"10.3389\/fnut.2025.1660065","volume":"12","author":"Q Liu","year":"2025","unstructured":"Liu Q, Luan H, Duan Z, Ai J, Wang Y, Chen P (2025) Efficacy of flavonoids in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis. Front Nutr 12:1660065","journal-title":"Front Nutr"},{"key":"5969_CR10","doi-asserted-by":"publisher","first-page":"1669478","DOI":"10.3389\/fendo.2025.1669478","volume":"16","author":"MS Mohiuddin","year":"2025","unstructured":"Mohiuddin MS, Neha NT, Mahir JUK, Shakib FAF, Alam MA, Wahiduzzaman M, Barua R, Shimu SJ, Rahman M, Hossain MR, Shariare MH, Mohib MM, Uddin MB (2025) Metabolic dysfunction associated fatty liver disease and type 2 diabetes: pathophysiological links, epidemiological trends, and clinical implications. Front Endocrinol (Lausanne) 16:1669478","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5969_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-nutr-071715-050718","volume":"36","author":"EE Mulvihill","year":"2016","unstructured":"Mulvihill EE, Burke AC, Huff MW (2016) Citrus flavonoids as regulators of lipoprotein metabolism and atherosclerosis. Annu Rev Nutr 36:275\u2013299","journal-title":"Annu Rev Nutr"},{"key":"5969_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.18773\/austprescr.2026.014","volume":"49","author":"R O'Halloran","year":"2026","unstructured":"O\u2019Halloran R, Adams LA, Deed G, Lubel JS (2026) Metabolic dysfunction-associated fatty liver disease: an update. Aust Prescr 49:44\u201349","journal-title":"Aust Prescr"},{"key":"5969_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bioorg.2013.07.001","volume":"50","author":"F Rodr\u00edguez-Ramos","year":"2013","unstructured":"Rodr\u00edguez-Ramos F, Navarrete A, Gonz\u00e1lez-Andrade M, Alarc\u00f3n C, Aguilera-Cruz A, Reyes-Ram\u00edrez A (2013) Synthesis, docking study and relaxant effect of 2-alkyl and 2-naphthylchromones on rat aorta and guinea-pig trachea through phosphodiesterase inhibition. Bioorg Chem 50:17\u201325","journal-title":"Bioorg Chem"},{"key":"5969_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012605","author":"NF Shamsudin","year":"2022","unstructured":"Shamsudin NF, Ahmed QU, Mahmood S, Shah SAA, Sarian MN, Khattak M, Khatib A, Sabere ASM, Yusoff YM, Latip J (2022) Flavonoids as antidiabetic and anti-inflammatory agents: a review on structural activity relationship-based studies and meta-analysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012605","journal-title":"Int J Mol Sci"},{"key":"5969_CR15","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.2147\/DDDT.S514498","volume":"19","author":"Z Song","year":"2025","unstructured":"Song Z, Bu S, Sang S, Li J, Zhang X, Song X, Ran Y (2025) The active components of traditional Chinese medicines regulate the multi-target signaling pathways of metabolic dysfunction-associated fatty liver disease. Drug des Devel Ther 19:2693\u20132715","journal-title":"Drug des Devel Ther"},{"issue":"8","key":"5969_CR16","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.3390\/ijms26083804","volume":"26","author":"P Taweesap","year":"2025","unstructured":"Taweesap P, Potue P, Khamseekaew J, Iampanichakul M, Jan OB, Pakdeechote P, Maneesai P (2025) Luteolin relieves metabolic dysfunction-associated fatty liver disease caused by a high-fat diet in rats through modulating the AdipoR1\/AMPK\/PPAR\u03b3 signaling pathway. Int J Mol Sci 26(8):3804","journal-title":"Int J Mol Sci"},{"key":"5969_CR17","first-page":"12","volume":"13","author":"TY Wang","year":"2018","unstructured":"Wang TY, Li Q, Bi KS (2018) Bioactive flavonoids in medicinal plants: structure, activity and biological fate. Asian J Pharm Sci 13:12\u201323","journal-title":"Asian J Pharm Sci"},{"key":"5969_CR18","doi-asserted-by":"publisher","first-page":"7075","DOI":"10.1021\/jf101415v","volume":"58","author":"CH Wu","year":"2010","unstructured":"Wu CH, Yang MY, Chan KC, Chung PJ, Ou TT, Wang CJ (2010) Improvement in high-fat diet-induced obesity and body fat accumulation by a Nelumbo nucifera leaf flavonoid-rich extract in mice. J Agric Food Chem 58:7075\u20137081","journal-title":"J Agric Food Chem"},{"key":"5969_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu8120799","author":"SF Xia","year":"2016","unstructured":"Xia SF, Le GW, Wang P, Qiu YY, Jiang YY, Tang X (2016) Regressive effect of myricetin on hepatic steatosis in mice fed a high-fat diet. Nutrients. https:\/\/doi.org\/10.3390\/nu8120799","journal-title":"Nutrients"},{"key":"5969_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113380","volume":"264","author":"PT Xiao","year":"2021","unstructured":"Xiao PT, Liu SY, Kuang YJ, Jiang ZM, Lin Y, Xie ZS, Liu EH (2021) Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia. J Ethnopharmacol 264:113380","journal-title":"J Ethnopharmacol"},{"key":"5969_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qiu W, Xiao J, Sun J, Ren X, Jiang L (2024) Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway. J Transl Med 22:309","journal-title":"J Transl Med"},{"key":"5969_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17453","author":"L Yuan","year":"2025","unstructured":"Yuan L, Cai Y, Wang G, Liu X, Chen B, Zhou D, Wu Y, Qu N, Li X, Zhou W (2025) SGK3 promotes estrogen receptor-positive breast cancer proliferation by activating STAT3\/ZMIZ2 pathway to stabilise \u03b2-catenin. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.17453","journal-title":"Br J Pharmacol"},{"key":"5969_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phytochem.2018.10.015","volume":"157","author":"YZ Zheng","year":"2019","unstructured":"Zheng YZ, Deng G, Chen DF, Guo R, Lai RC (2019a) The influence of C2C3 double bond on the antiradical activity of flavonoid: different mechanisms analysis. Phytochemistry 157:1\u20137","journal-title":"Phytochemistry"},{"key":"5969_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2019.112075","volume":"166","author":"YZ Zheng","year":"2019","unstructured":"Zheng YZ, Deng G, Guo R, Fu ZM, Chen DF (2019b) Theoretical insight into the antioxidative activity of isoflavonoid: the effect of the C2=C3 double bond. Phytochemistry 166:112075","journal-title":"Phytochemistry"},{"key":"5969_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108864","author":"C Zhong","year":"2025","unstructured":"Zhong C, Deng K, Lang X, Shan D, Xie Y, Pan W, Yu J (2025) Therapeutic potential of natural flavonoids in atherosclerosis through endothelium-protective mechanisms: an update. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108864","journal-title":"Pharmacol Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05969-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:02:14Z","timestamp":1791558134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05969-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":25,"alternative-id":["5969"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05969-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"31 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were performed in strict accordance with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee of Chongqing Medical University (IACUC-CQMU-2024\u20130430). All operations were carried out by personnel who had received professional training and were proficient in the techniques used.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final version of the manuscript and agree to submit. This manuscript represents the authors\u2019 original work and has not been published previously, nor is it being considered for publication elsewhere, in whole or in part, in any language.","order":3,"name":"Ethics","label":"Author agreements","group":{"name":"EthicsHeading","label":"Declarations"}}]}}